Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
1.640
+0.095 (6.15%)
At close: Dec 20, 2024, 4:00 PM
1.630
-0.010 (-0.61%)
After-hours: Dec 20, 2024, 6:50 PM EST
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,627,487
Market Cap
260.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TruBridge | 3,219 |
| OraSure Technologies | 638 |
| Lifecore Biomedical | 524 |
| Lexicon Pharmaceuticals | 285 |
| iTeos Therapeutics | 157 |
| Rezolute | 51 |
| Larimar Therapeutics | 42 |
| Eledon Pharmaceuticals | 20 |
RENB News
- 1 day ago - Renovaro Regains Compliance with NASDAQ Listing Requirement - GlobeNewsWire
- 1 day ago - Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection - GlobeNewsWire
- 6 weeks ago - Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewsWire
- 2 months ago - RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing - GlobeNewsWire
- 2 months ago - Renovaro Announces Strategic Restructuring and Leadership Transition - GlobeNewsWire
- 3 months ago - RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress - GlobeNewsWire
- 3 months ago - RenovaroCube Announces Strategic Offering of Up to 20% Ownership - GlobeNewsWire
- 6 months ago - Renovaro, Inc. Announces $10 million in Equity Committed - GlobeNewsWire